Program Overview
Please read the following information about this educational activity before accessing the presentations using links located at the bottom of this page.
| Release Date: March 15, 2009 | Expiration Date: March 14, 2010 |
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2 hours (0.2 CEUs) of continuing education credit.
Program number 204-000-08-473-H01P.
Methods and Format
This is an online activity consisting of audio and slides for three presentations, a post-test, and an activity evaluation tool. Participants must view all three presentations, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.
Target Audience
This program is designed for pharmacists who are involved with formulary decision-making and the care of patients who are candidates for botulinum toxin therapy or who are already receiving botulinum toxin therapy.
Activity Content
Click here to view an overview of the activity content.
Learning Objectives
After participating in this knowledge-based educational activity, participants should be able to
- Explain the mechanism of action and pharmacologic effects of botulinum toxin.
- Compare characteristics of botulinum toxin type A and type B products currently available.
- Identify at least one FDA-approved therapeutic indication for botulinum toxin type A and type B.
- Characterize the new and emerging evidence supporting or refuting the use of botulinum toxin for at least two other indications, such as autonomic disorders and pain, movement disorders, and spasticity.
- Identify at least three issues affecting the FDA's governance, clinical monitoring, and interchangeability of biosimilar products.
Faculty
Richard G. Wenzel, Pharm.D., Program Moderator
Diamond Headache Clinic Inpatient Unit
St. Joseph's Hospital
Chicago, Illinois
Evelyn Hermes DeSantis, Pharm.D., BCPS
Clinical Associate Professor
Ernest Mario School of Pharmacy
Rutgers University
Director, Drug Information Center
Robert Wood Johnson University Hospital
Piscataway, New Jersey
David M. Simpson, M.D.
Professor of Neurology
Director, Clinical Neurophysiology Laboratories
Director, Neuro-AIDS Program
Mount Sinai Medical Center
New York, New York
Disclosure Statements
In accordance with the Accreditation Council for Continuing Medical Education's and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
Evelyn Hermes DeSantis, Pharm.D., BCPS
Dr. Hermes DeSantis declares that she has no relationships pertinent to this activity.
David M. Simpson, M.D.
Dr. Simpson declares that he has no relationships pertinent to this activity.
Richard G. Wenzel, Pharm.D.
Dr. Wenzel declares that he has no relationships pertinent to this activity.
Benjamin I. Dickinson, Pharm.D.
Dr. Dickinson declares that he has no relationships pertinent to this activity.
This activity is supported by an educational grant from Allergan, Inc.
Launch Presentation
-
Pharmacology of Botulinum Toxin and Characteristics of Available Products
Evelyn Hermes DeSantis, Pharm.D., BCPS
(26 minutes) -
Current and Emerging Therapeutic Uses of Botulinum Toxin
David M. Simpson, M.D.
(42 minutes) -
Pharmacy Considerations Related to the Use of Biosimilars in Health Systems
Richard G. Wenzel, Pharm.D.
(36 minutes)
If you would prefer the podcast format of this activity, click here.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
This activity is planned and coordinated by ASHP Advantage.